Samenvatting
De levensverwachting van personen met trisomie 21 is spectaculair toegenomen. Meer volwassenen leven langer. De opvolging van kinderen met trisomie 21 gebeurt op systematische en gecoördineerde manier om op gezondheidsproblemen te anticiperen en tijdig te herkennen. Dat is bij volwassenen minder het geval. Gecoördineerde, systematische opvolging van de gezondheid van volwassenen met trisomie 21 wordt wel in de literatuur aanbevolen en kan een belangrijke impact hebben op de gezondheidstoestand en kwaliteit van leven. De huisarts bekleedt een ideale positie om deze zorg te coördineren. Deze bijdrage geeft een beknopt overzicht van de verschillende gezondheidsproblemen en een stelt een schema voor opvolging voor.
Literatuur
Bittles AH, Glasson EJ. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol. 2004;46:282–6.
Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. Eur J Public Health 2007;17:221–5.
Real de Asua D, Quero M, Moldenhauer F, Suarez C. Clinical profile and main comorbidities of Spanish adults with Down syndrome. Eur J Intern Med. 2015;26:385–91.
Gardiner K. Transcriptional dysregulation in Down syndrome: predictions for altered protein complex stoichiometries and post-translational modifications, and consequences for learning/behavior genes ELK, CREB, and the estrogen and glucocorticoid receptors. Behav Genet. 2006;36:439–53.
Nakamura E, Tanaka S. Biological ages of adult men and women with Down’s syndrome and its changes with aging. Mech Ageing Dev. 1998;105:89–103.
Esbensen AJ. Health conditions associated with aging and end of life of adults with Down syndrome. Int Rev Res Ment Retard. 2010;39:107–26.
Carfi A, Antocicco M, Brandi V, Cipriani C, Fiore F, Mascia D, et al. Characteristics of adults with down syndrome: prevalence of age-related conditions. Front Med. (Lausanne) 2014;1:51.
Smith DS. Health care management of adults with Down syndrome. Am Fam Physician. 2001;64:1031–8.
Delle Chiaie B, Van den Braembussche S, Elsing C, Ent S van der, Leroy R, Callewaert B, et al. Adults with Down syndrome – health/care considerations for health professionals. Tijdschr Belg Kinderarts. 2012;14:56–61.
Jensen KM, Bulova PD. Managing the care of adults with Down’s syndrome. BMJ. 2014;349:g5596.
Henderson A, Lynch SA, Wilkinson S, Hunter M. Adults with Down’s syndrome: the prevalence of complications and health care in the community. Br J Gen Pract. 2007;57:50–5.
Bertoli M, Biasini G, Calignano MT, Celani G, De Grossi G, Digilio MC, et al. Needs and challenges of daily life for people with Down syndrome residing in the city of Rome, Italy. J Intellect Disabil Res. 2011;55:801–20.
Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down’s syndrome: prevalence, management and diabetic complications. Diabet Med. 1998;15:160–3.
Seltzer GB, Schupf N, Wu HS. A prospective study of menopause in women with Down’s syndrome. J Intellect Disabil Res. 2001;45:1–7.
Patel BN, Seltzer GB, Wu HS, Schupf N. Effect of menopause on cognitive performance in women with Down syndrome. Neuroreport. 2001;12:2659–62.
Prasher VP. Overweight and obesity amongst Down’s syndrome adults. J Intellect Disabil Res. 1995;39 (Pt 5):437–41.
Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989;46:849–53.
Schupf N, Pang D, Patel BN, Silverman W, Schubert R, Lai F, et al. Onset of dementia is associated with age at menopause in women with Down’s syndrome. Ann Neurol. 2003;54:433–8.
Ball SL, Holland AJ, Hon J, Huppert FA, Treppner P, Watson PC. Personality and behaviour changes mark the early stages of Alzheimer’s disease in adults with Down’s syndrome: findings from a prospective population-based study. Int J Geriatr Psychiatry 2006;21:661–73.
Lott IT, Dierssen M. Cognitive deficits and associated neurological complications in individuals with Down’s syndrome. Lancet Neurol. 2010;9:623–33.
Gedye A. Dementia Scale for Down’s Syndrome. Vancouver: Gedye Research and Consulting; 1995.
Strydom A, Hassiotis A. Diagnostic instruments for dementia in older people with intellectual disability in clinical practice. Aging Ment Health 2003;7:431–37.
Lott IT, Doran E, Nguyen VQ, Tournay A, Movsesyan N, Gillen DL. Down syndrome and dementia: seizures and cognitive decline. J Alzheimers Dis. 2012;29:177–85.
Evenhuis HM. The natural history of dementia in Down’s syndrome. Arch Neurol. 1990;47:263–7.
De Simone R, Puig XS, Gelisse P, Crespel A, Genton P. Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer’s disease in Down syndrome. Seizure 2010;19:383–9.
Aller-Alvarez JS, Menendez-Gonzalez M, Ribacoba-Montero R, Salvado M, Vega V, Suarez-Moro R, et al. Myoclonic epilepsy in Down syndrome and Alzheimer disease. Neurologia 2015. doi:10.1016/j.nrl.2014.12.008
Sobey CG, Judkins CP, Sundararajan V, Phan TG, Drummond GR, Srikanth VK. Risk of Major Cardiovascular Events in People with Down Syndrome. PLoS One 2015;10:e0137093.
Coppus AM, Evenhuis HM, Verberne GJ, Visser FE, Oostra BA, Eikelenboom P, et al. Survival in elderly persons with Down syndrome. J Am Geriatr Soc. 2008;56:2311–16.
Uppal H, Chandran S, Potluri R. Risk factors for mortality in Down syndrome. J Intellect Disabil Res. 2015;59:873–81.
Trois MS, Capone GT, Lutz JA, Melendres MC, Schwartz AR, Collop NA, et al. Obstructive sleep apnea in adults with Down syndrome. J Clin Sleep Med. 2009;5:317–23.
Lal C, Strange C, Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest 2012;141:1601–10.
Elsing C, Ent S van der. Systematische gezondheidsfollow-up van volwassenen met Downsyndroom met een Downpas 18 +. University of Antwerp. Unpublished Work; 2013.
Juj H, Emery H. The arthropathy of Down syndrome: an underdiagnosed and under-recognized condition. J Pediatr. 2009;154:234–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Van Goethem, G., Dieleman, P. & Wojciechowski, M. Ouder worden met trisomie 21. Bijblijven 32, 40–51 (2016). https://doi.org/10.1007/s12414-016-0112-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12414-016-0112-y